Portfolio Company Fees in Private Equity

Portfolio company fees are ancillary charges that private equity GPs collect from their operating portfolio companies—monitoring, transaction, board advisory, and other services—that can materially offset management fees paid by the fund and should be heavily scrutinized by LPs to ensure they are reasonable and fully disclosed.

The Two-Tier Fee Structure in PE

Traditional private equity returns to LPs are built on a two-tier model:

1. Management fees: Annual charge (typically 1.5–2%) on committed or invested capital, paid by LPs to cover fund operations, team salaries, office overhead.
2. Carried interest: GP’s 20% (or negotiated percentage) of profits above a hurdle rate.

This model aligns GP and LP incentives in theory: the GP eats management fees (taking losses if the fund underperforms) and earns carried interest only if returns exceed a target. LPs are protected.

But a third layer exists: portfolio company fees. These are charges that GPs bill directly to the operating companies they own, bypassing the LP-level fee structure entirely. This is where complexity and opacity thrive.

Types of Portfolio Company Fees

Monitoring fees are the most common. The GP claims the fund staff needs to monitor each portfolio company’s financial performance, strategy, governance, and risk. Instead of rolling this cost into management fees (which LPs pay), the GP invoices the portfolio company directly—often 0.5–1% of revenue or EBITDA annually.

A PE fund might manage 8–12 portfolio companies with $500M total revenue. Monitoring fees of 0.75% portfolio revenue = $3.75M annually. Gross. That’s a material income stream, and it flows to the GP, not the LP-fund.

Transaction fees appear when the portfolio company buys or sells a subsidiary, refinances debt, or pursues a bolt-on acquisition. The GP’s deal team orchestrates the transaction and bills the portfolio company 0.5–2% of deal value. A $100M bolt-on acquisition might generate $500K–$2M in fees to the GP.

Board advisory or monitoring committee fees are charged for board service, financial advisory, or special projects. GPs often staff portfolio company boards with their own partners and associates, then invoice the company for those services.

Debt arrangement fees are charged when the GP’s debt team arranges or refinances the company’s credit lines or bond issuances. These can be 1–2% of facility size.

Add-on acquisition fees are charged when the GP sources, evaluates, or integrates add-on companies. These often overlap suspiciously with monitoring fees and transaction advisory.

The Offset Mechanism: How Portfolio Fees Reduce Gross Returns to LPs

This is the crux of LP disclosure risk. Portfolio company fees directly reduce the cash available to the fund, which reduces the denominator used to calculate carried interest.

Example:

A $1B PE fund holds 10 companies with $200M aggregate EBITDA. The fund pays $15M in annual management fees (1.5% of $1B committed capital). The fund also collects $3M in monitoring fees from portfolio companies (1.5% of $200M EBITDA).

From the LP’s perspective, net operating costs to the fund are $12M, not $15M. But if the GP presents the $15M as its management fee and buries the $3M portfolio company receipts in operating costs or reinvested capital, the GP’s effective cost to the fund is lower than LPs believe—meaning LPs’ net returns are compressed.

Worse, when distributions happen, the GP may calculate carried interest on gross profit before portfolio company fees are deducted, inflating GP profits.

Transparency Issues and LP Leverage Points

Many PE fund LP agreements are silent or vague on portfolio company fees. The fund documents might state: “The GP may charge portfolio companies for monitoring, transaction advisory, and other services at market rates.” That’s broad. “Market rates” for what? To whom is this disclosed?

A 2020+ trend among large LPs (university endowments, pension funds, insurance companies) has been demanding:

1. Explicit caps: Monitoring fees capped at 0.75% of portfolio company revenue, not revenue + EBITDA combined.
2. Full disclosure schedules: A line-item list of every fee charged to every portfolio company each year.
3. Offsets to management fees: Portfolio company fees should directly reduce LP-side management fee calculations or be credited back to the fund.
4. Carve-outs for double-dipping: If a service is already included in management fees (e.g., general monitoring), it should not be charged again to the portfolio company.
5. Independent audit: Third-party verification that fees charged are reasonable and documented.

Smaller LPs often lack this leverage and accept boilerplate language. Larger LPs now demand custom terms.

Red Flags in Portfolio Company Fee Structures

Monitoring fees on mature, stable companies. A mature software company with recurring revenue, stable margins, and experienced management requires minimal “monitoring.” If a GP is charging 1% EBITDA monitoring on a $20M EBITDA software company ($200K annually), ask: what specifically is being monitored that doesn’t happen in the annual board meeting? GPs often justify monitoring fees as “covering the cost of due diligence and financial hygiene,” but mature companies don’t need the same ongoing scrutiny as turnarounds or distressed situations.

Transaction fees overlapping with monitoring. If the GP charges 0.75% monitoring and also 1.5% transaction fees on bolt-on acquisitions, there’s risk of double-counting. The bolt-on’s integration is arguably a monitoring function. Demand clarity on what’s included in each.

Undefined “advisory” fees. Language like “occasional advisory services as requested by the portfolio company board” is too loose. This can expand to cover team members’ time on non-core projects, inflating charges.

Fees increasing over time. A monitoring fee that starts at 0.5% and drifts to 1.5% as the portfolio company grows suggests the fee is not truly proportional to effort—it’s a hidden escalator.

No offset for underperformance. If a portfolio company’s EBITDA falls 20% due to market downturn, do monitoring fees fall proportionally? If not, the fee structure is truly fixed to revenue, not to GP effort, which is transparent but potentially aggressive.

What LPs Should Do

1. Model the impact: Calculate portfolio company fees as a percentage of fund EBITDA and add-on acquisition value. Across a $1B fund, 0.75% monitoring + 1% transaction fees can easily reduce net LP returns by 50–100 basis points annually.
2. Demand full schedules: Request (and audit) the actual invoices from portfolio companies to the GP. This is your money; you own the right to inspect.
3. Benchmark against peers: Ask the GP which other (non-competing) funds charge for similar services, and what rates. If the GP’s monitoring fees are 2% and the market is 0.5–0.75%, push back.
4. Negotiate caps and offsets: Insist that portfolio company fees are capped per company and that excess fees above a threshold offset management fees.
5. Align incentives: Tie portfolio company fees to specific milestones or metrics. If the GP’s “monitoring” actually improves portfolio company EBITDA or reduces leverage, that’s justified. If it’s a flat tax, resist.

See also